» Articles » PMID: 6593107

Neuropeptide Y Potentiates the Effect of Various Vasoconstrictor Agents on Rabbit Blood Vessels

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 1984 Oct 1
PMID 6593107
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

The contractile effect of neuropeptide Y (NPY) was tested on isolated segments of basilar artery, central ear artery, gastro-epiploic artery and vein, and femoral artery and vein from the rabbit. At 30 nM NPY did not evoke vasoconstriction; at 300 nM NPY evoked a weak and variable response. NPY greatly potentiated the response of the gastro-epiploic and femoral arteries to noradrenaline without affecting the maximum response. As tested on the gastro-epiploic artery NPY was effective at concentrations of 1 nM and higher. As tested on the femoral artery the potentiating effect of 30 nM NPY on noradrenaline-evoked contractions was apparent immediately and 30 min after the application of NPY, but not after one hour. NPY (30 nM) potentiated the contractile response to noradrenaline and histamine but not to 5-hydroxytryptamine or high K+. The response to histamine was augmented in both arteries and veins, whereas the response to noradrenaline was enhanced in arteries but not in veins. NPY failed to potentiate the prostaglandin F2 alpha-evoked contraction except in the gastro-epiploic vein.

Citing Articles

Feedforward inhibition of stress by brainstem neuropeptide Y neurons.

Zhang Y, Shen J, Xie F, Liu Z, Yin F, Cheng M Nat Commun. 2024; 15(1):7603.

PMID: 39217143 PMC: 11365948. DOI: 10.1038/s41467-024-51956-9.


Peri-arterial Autonomic Innervation of the Human Ear.

Cakmak Y, Cotofana S, Jager C, Morawski M, Sora M, Werner M Sci Rep. 2018; 8(1):11469.

PMID: 30065349 PMC: 6068185. DOI: 10.1038/s41598-018-29839-z.


Sympathetic control of reflex cutaneous vasoconstriction in human aging.

Greaney J, Alexander L, Kenney W J Appl Physiol (1985). 2015; 119(7):771-82.

PMID: 26272321 PMC: 4593810. DOI: 10.1152/japplphysiol.00527.2015.


Remodeling of stellate ganglion neurons after spatially targeted myocardial infarction: Neuropeptide and morphologic changes.

Ajijola O, Yagishita D, Reddy N, Yamakawa K, Vaseghi M, Downs A Heart Rhythm. 2015; 12(5):1027-35.

PMID: 25640636 PMC: 4411181. DOI: 10.1016/j.hrthm.2015.01.045.


Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.

Enman N, Sabban E, McGonigle P, Van Bockstaele E Neurobiol Stress. 2014; 1:33-43.

PMID: 25506604 PMC: 4260418. DOI: 10.1016/j.ynstr.2014.09.007.


References
1.
Bolton T . Mechanisms of action of transmitters and other substances on smooth muscle. Physiol Rev. 1979; 59(3):606-718. DOI: 10.1152/physrev.1979.59.3.606. View

2.
Tatemoto K, Carlquist M, Mutt V . Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982; 296(5858):659-60. DOI: 10.1038/296659a0. View

3.
Tatemoto K . Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A. 1982; 79(18):5485-9. PMC: 346928. DOI: 10.1073/pnas.79.18.5485. View

4.
Lundberg J, Tatemoto K . Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand. 1982; 116(4):393-402. DOI: 10.1111/j.1748-1716.1982.tb07157.x. View

5.
Lundberg J, Terenius L, Hokfelt T, Martling C, Tatemoto K, Mutt V . Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982; 116(4):477-80. DOI: 10.1111/j.1748-1716.1982.tb07171.x. View